FAB: Omega-3 and Schizophrenia

Alcohol: What Women Need to Know - BOOK HERE

Omega-3 and Schizophrenia - Research

Bozzatello P et al 2021 - Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids
Bozzatello et al 2019 - Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
Firth et al 2019 - The efficacy and safety of nutrient supplements in the treatment of mental disorders
Chang & Su 2019 - Nutrition and immunology in mental health: Precision medicine and integrative approaches to address unmet clinical needs in psychiatric treatments
Firth et al 2018 - Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms.
Hoenders et al 2018 - Natural Medicines for Psychotic Disorders: A Systematic Review
Agostoni et al 2017 - The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD.
Marx et al 2017 - Nutritional psychiatry: the present state of the evidence.
Maekawa et al 2017 - Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes
Qiao et al 2017 - Effects of Omega-3 in the treatment of violent schizophrenia patients.
Underwood 2017 - Omega-3 fatty acids to prevent psychosis: the importance of replication (NEURAPRO trial)
McGorry et al 2017 - Effect of Omega-3 PUFA in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO RCT
Kane & Correll 2017 - Omega-3 Polyunsaturated Fatty Acids to Prevent Psychosis - The Importance of Replication Studies
Tesei et al 2016 - The potential relevance of DHA and EPA to childhood neuropsychiatric disorders.
Bozzatello et al 2016 - Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data.
Pawelczyk et al 2016 - Association between PUFA consumption and the transition to psychosis in ultra-high risk individuals
Pawelczyk et al 2016 - A randomized controlled study of supplementation with omega-3 PUFA in first episode schizophrenia
Amminger et al 2015 - Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study.
Zaalberg 2015 - Nutrition, Neurotoxicants and Aggressive Behaviour
Patrick & Ames, 2015 - Vitamin D and omega-3 control serotonin synthesis and action, part 2: relevance for ADHD, bipolar, schizophrenia, and impulsive behavior.
Sarris et al 2015 - Nutritional medicine as mainstream in psychiatry
Arroll et al, 2014 - Nutritional interventions for the adjunctive treatment of schizophrenia
Schimamoto et al, 2014 - Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder
Mischoulon & Freeman 2013 - Omega-3 fatty acids in psychiatry
Politi et al 2011 - Randomized Placebo-Controlled Trials of Omega-3 Polyunsaturated Fatty Acids in Psychiatric Disorders: a Review of Current Literature
Harper KN et al 2011 - Maternal serum docosahexaenoic acid and schizophrenia spectrum disorders in adult offspring
De Souza et al 2011 - Effects of maternal malnutrition and postnatal nutritional rehabilitation on brain fatty acids, learning, and memory
Lafourcade et al 2011 - Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions
Sethom et al 2010 - PUFA deficits associated with psychotic state in schizophrenia
Hedelin et al 2010 - Dietary intake of fish, omega-3, omega-6 PUFA and vitamin D and psychotic-like symptoms in women from the general population.
Amminger et al 2010 - Long-chain omega-3 for prevention of psychosis: RCT
Fedorova et al 2009 - Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency.
Brown & Susser 2008 - Prenatal nutritional deficiency and risk of adult schizophrenia
Berger et al 2008 - Ethyl-EPA in first-episode psychosis. A 1H-MRS study
Rapoport 2008 - Brain AA and DHA cascades are selectively altered by drugs, diet and disease.
Richardson 2008 - Omega-3 Fatty acids and Mood: The Devil is in the Detail
Hallahan and Garland 2007 - Essential fatty acids and mental health (editorial)
Garland et al. 2007 - Lipids and EFAs in patients presenting with self-harm
Mazza et al 2007 - Omega-3 and antioxidants in neurological and psychiatric diseases: an overview.
Freeman et al. 2006 - Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry
Joy et al 2006 - Polyunsaturated fatty acid supplementation for schizophrenia
Berger et al 2006 - Bioactive lipids in schizophrenia.
Mahadik et al 2006 - Prevention of oxidative stress and improved clinical outcome by adjunctive use of antioxidants and omega-3 in schizophrenia.
Saugstad 2006 - Are neurodegenerative disorders and psychotic manifestations avoidable with adequate dietary omega-3?
Vaddadi 2006 - Essential fatty acids and mental illness.
Vaddadi et al 2006 - Tardive dyskinesia and essential fatty acids
du Bois et al 2005 - Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia.
Peet 2004 - International variations in schizophrenia outcome and depression prevalence in relation to national diet
Peet 2003 - EPA in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.
Raine et al 2003 - Effects of Environmental Enrichment at Ages 3-5 Years on Schizotypal Personality and Antisocial Behavior at Ages 17 and 23 Years

Food and Behaviour Research is a registered charity (No SC034604) and a company limited by guarantee (Co No SC 253448)

Newsletter Signup

Useful Links

Contact Us

FAB Research
23 Carlton Road
Oxford
OX2 7SA

Important Notice

Medical opinion and guidance should always be sought for any symptoms that might possibly reflect a known or suspected disease, disorder or medical condition. Information provided on this website (or by FAB Research via any other means) does not in any way constitute advice on the treatment of any medical condition formally diagnosed or otherwise.